Pharmacophore-guided optimization of the hit compound CTN1122 in the design of promising imidazo[1,2-]pyrazine derivatives targeting the casein kinase 1 for antileishmanial therapy.

Documenti analoghi

• Investigating the C2 Modulation of the Imidazo[1,2‐a]pyrazine‐Based Hit Compound CTN1122: Synthesis, in vitro Antileishmanial Activity, Cytotoxicity and Casein Kinase 1 Inhibition
  di: Lhana Tisseur, et al.
  Pubblicazione: (2025)
• Investigating the C2 Modulation of the Imidazo[1,2-a]pyrazine-Based Hit Compound CTN1122: Synthesis, in vitro Antileishmanial Activity, Cytotoxicity and Casein Kinase 1 Inhibition.
  di: Tisseur, Lhana, et al.
  Pubblicazione: (2025)
• Looking for Fairness in Recommender Systems
  di: Logé, Cécile
  Pubblicazione: (2025)
• Von Bauingenieurinnen und Sozialarbeitern
  di: Loge, Lena
  Pubblicazione: (2021)
• Boletín CTN Diocean No. 2/ 2022
  Pubblicazione: ()